(Q37415276)

English

MYC and EIF3H Coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitinib.

scientific article published on April 2009

Statements

MYC and EIF3H Coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitinib. (English)
Marileila Varella-Garcia
Elisa Rossi
Sujatha Gajapathy
Marialuisa Valente
Harry Drabkin
Robert Gemmill
1 April 2009
472-478

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit